• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[恶性肺肿瘤——组织形态学分类、免疫组织学技术及预后因素]

[Malignant lung tumors--histomorphological classification, immunohistological techniques and prognostic factors].

作者信息

Fisseler-Eckhoff A

机构信息

Institut für Pathologie, Zentralklinik Emil-von-Behring, Gimpelsteig 3-9, 14165 Berlin.

出版信息

Kongressbd Dtsch Ges Chir Kongr. 2001;118:590-5.

PMID:11824322
Abstract

Histological typing of lung tumors is based on the new WHO-IASLC classification of lung and pleural tumors published in 1999. Based on histological growth pattern, the major light microscopic categories of lung carcinomas are squamous cell carcinoma, small cell carcinoma, adenocarcinoma and large cell carcinoma. The further subclassification within the main categories resembles the high degree of lung tumor heterogeneity. Immunohistochemistry may detect differentiation that cannot be seen by routine light microscopy on small bioptically obtained specimens. Evaluation of the proliferation index of tumor cells, hormonal receptors, oncogenes and tumor-suppressor genes is possible. Oncogenes, tumor-suppressor genes, angiogenetical factors as well as single cell dissemination of tumor cells in lymph nodes are discussed as possible prognostic factors.

摘要

肺肿瘤的组织学分类基于1999年出版的世界卫生组织-国际肺癌研究协会(WHO-IASLC)关于肺和胸膜肿瘤的新分类。根据组织学生长模式,肺癌的主要光镜类别为鳞状细胞癌、小细胞癌、腺癌和大细胞癌。主要类别内的进一步细分反映了肺肿瘤高度的异质性。免疫组织化学可检测在小活检标本上常规光镜无法观察到的分化情况。评估肿瘤细胞的增殖指数、激素受体、癌基因和肿瘤抑制基因是可行的。癌基因、肿瘤抑制基因、血管生成因子以及肿瘤细胞在淋巴结中的单细胞播散被作为可能的预后因素进行讨论。

相似文献

1
[Malignant lung tumors--histomorphological classification, immunohistological techniques and prognostic factors].[恶性肺肿瘤——组织形态学分类、免疫组织学技术及预后因素]
Kongressbd Dtsch Ges Chir Kongr. 2001;118:590-5.
2
Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.中国Ⅰ期非小细胞肺癌中T描述符及其他预后因素分析
J Thorac Oncol. 2009 Jun;4(6):702-9. doi: 10.1097/JTO.0b013e3181a5269d.
3
The new tumor, node, and metastasis staging system.新的肿瘤、淋巴结和转移分期系统。
Semin Respir Crit Care Med. 2011 Feb;32(1):44-51. doi: 10.1055/s-0031-1272868. Epub 2011 Apr 15.
4
[Clinical classification of central lung cancer in the light of late results of surgical treatment].[基于手术治疗晚期结果的中央型肺癌临床分类]
Vestn Khir Im I I Grek. 1990 Jul;145(7):117-20.
5
[The surgical therapy of stage-III pulmonary cancer. Comments on 71 cases].[III期肺癌的外科治疗。对71例病例的评论]
Minerva Med. 1989 Jul;80(7):677-8.
6
[Small-cell bronchogenic cancer one year after excision of 2 synchronous non-small-cell bronchogenic cancers].[2例同步性非小细胞支气管源性癌切除术后1年发生小细胞支气管源性癌]
Rev Pneumol Clin. 1999 Sep;55(4):231-2.
7
[The new TNM classification in lung cancer].[肺癌的新TNM分类]
Pneumonol Alergol Pol. 2010;78(6):407-17.
8
[Lung tumors. Pathologic-anatomic diagnosis].[肺肿瘤。病理解剖诊断]
Internist (Berl). 1994 Aug;35(8):710-23.
9
Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens.小细胞肺癌(SCLC):100例手术标本的临床病理研究
Am J Surg Pathol. 2002 Sep;26(9):1184-97. doi: 10.1097/00000478-200209000-00009.
10
[Extensive and combined resections in poorly differentiated lung cancer].[低分化肺癌的广泛联合切除术]
Vestn Khir Im I I Grek. 1992 Apr;148(4):43-9.

引用本文的文献

1
Opposed expression of IKKα: loss in keratinizing carcinomas and gain in non-keratinizing carcinomas.IKKα的相反表达:在角化性癌中缺失而在非角化性癌中增加。
Oncotarget. 2015 Sep 22;6(28):25499-505. doi: 10.18632/oncotarget.4548.